524 related articles for article (PubMed ID: 17092741)
1. The thioredoxin system in cancer.
Arnér ES; Holmgren A
Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
3. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
4. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
7. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
9. Revival of glutathione reductase in human cataractous and clear lens extracts by thioredoxin and thioredoxin reductase, in conjunction with alpha-crystallin or thioltransferase.
Yan H; Harding JJ; Xing K; Lou MF
Curr Eye Res; 2007 May; 32(5):455-63. PubMed ID: 17514531
[TBL] [Abstract][Full Text] [Related]
10. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
11. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
[TBL] [Abstract][Full Text] [Related]
12. Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer.
Nakamura H; Masutani H; Yodoi J
Semin Cancer Biol; 2006 Dec; 16(6):444-51. PubMed ID: 17095246
[TBL] [Abstract][Full Text] [Related]
13. Selenium compounds and selenoproteins in cancer.
Brigelius-Flohé R
Chem Biodivers; 2008 Mar; 5(3):389-95. PubMed ID: 18357548
[TBL] [Abstract][Full Text] [Related]
14. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
Zhao R; Masayasu H; Holmgren A
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
[TBL] [Abstract][Full Text] [Related]
15. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.
Jönsson-Videsäter K; Björkhem-Bergman L; Hossain A; Söderberg A; Eriksson LC; Paul C; Rosén A; Björnstedt M
Biochem Pharmacol; 2004 Feb; 67(3):513-22. PubMed ID: 15037203
[TBL] [Abstract][Full Text] [Related]
16. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
17. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human thioredoxin reductase.
Söderberg A; Sahaf B; Holmgren A; Rosén A
Biochem Biophys Res Commun; 1998 Aug; 249(1):86-9. PubMed ID: 9705836
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome.
Kaimul AM; Nakamura H; Masutani H; Yodoi J
Free Radic Biol Med; 2007 Sep; 43(6):861-8. PubMed ID: 17697931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]